Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125834671 | 12583467 | 1 | I | 201602 | 20160718 | 20160722 | 20160722 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47177BP | BOEHRINGER INGELHEIM | 69.87 | YR | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125834671 | 12583467 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | ||||||
| 125834671 | 12583467 | 2 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | NEBULISER LIQUID | ||||||||||
| 125834671 | 12583467 | 3 | C | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 0 | NEBULISER LIQUID | ||||||||||
| 125834671 | 12583467 | 4 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 7 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 8 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 9 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 125834671 | 12583467 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125834671 | 12583467 | 1 | Product used for unknown indication |
| 125834671 | 12583467 | 2 | Product used for unknown indication |
| 125834671 | 12583467 | 3 | Product used for unknown indication |
| 125834671 | 12583467 | 4 | Product used for unknown indication |
| 125834671 | 12583467 | 5 | Product used for unknown indication |
| 125834671 | 12583467 | 6 | Product used for unknown indication |
| 125834671 | 12583467 | 7 | Product used for unknown indication |
| 125834671 | 12583467 | 8 | Product used for unknown indication |
| 125834671 | 12583467 | 9 | Product used for unknown indication |
| 125834671 | 12583467 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125834671 | 12583467 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125834671 | 12583467 | Malaise | |
| 125834671 | 12583467 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125834671 | 12583467 | 1 | 201007 | 0 |